ViewpointIL-6 and APPs: anti-inflammatory and immunosuppressive mediators☆
References (53)
- et al.
Adv. Immunol.
(1993) - et al.
Blood
(1994) - et al.
Biochem. Biophys. Res. Commun.
(1990) - et al.
Blood
(1990) - et al.
J. Biol. Chem.
(1991) - et al.
Blood
(1995) - et al.
Exp. Cell. Res.
(1994) - et al.
Immunol. Today
(1994) - et al.
J. Biol. Chem.
(1993) - et al.
Hepatology
New engl J Med
Eur. Cytokine Netw.
J. Clin. Endocrinol. Metab.
Eur. J. Immunol.
Inject. Immun.
Am. J. Pathol.
J. Exp. Med.
J. Immunol.
Br. J. Rheumatol.
Inflammation
DNA Cell Bull.
J. Immunol.
Nature
Science
Circ. Shock
Cited by (554)
Stress, aging, and inflammation
2023, Stress: Immunology and Inflammation: Handbook of Stress Series Volume 5Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?
2022, International ImmunopharmacologyCitation Excerpt :For example, secreted IL-6 leads to inhibition of TNF-α and IL-1 receptor antagonist expression, induces CD163 expression at the surface of monocytes, which results in their differentiation into M2 cells [106]. It also leads to the induction of oncogenesis during cancer and the expression of anti-apoptotic genes such as Mcl-1 [118–120]. CD163 is usually expressed to a small extent at the M1 macrophage surface and a large extent on the M2 macrophage membrane due to its expression on the monocyte-macrophage lineage’s surface [106,107].
Evaluation of triclosan exposures on secretion of pro-inflammatory cytokines from human immune cells
2021, Environmental Toxicology and PharmacologyTranscriptional regulation of retinol binding protein 4 by Interleukin-6 via peroxisome proliferator-activated receptor α and CCAAT/Enhancer binding proteins
2020, Molecular and Cellular EndocrinologyPhysical exercise in kidney disease: A commonly undervalued treatment modality
2024, European Journal of Clinical Investigation
- ☆
This work was supported by grants from the National Institute of Health (CA 43930, A1 15614), the American Cancer Society (ACS IM 943), the Burroughs Wellcome Foundation and the Austrian Government (grant P11379).